Upon analysing the proportions of T-cell subclusters in patients with ALS according to their clinical stage (Supplementary Fig. 4C and D), we noted an increase in the proportion of CD8+  GZMKhi TEMs as the clinical stage advanced. This evidence concerns the gene CD8A and amyotrophic lateral sclerosis.